Arteriovenous malformations future or investigational therapies: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Arteriovenous malformations}} | {{Arteriovenous malformations}} | ||
{{CMG}}; {{AE}} {{KD}} | {{CMG}}; {{AE}} {{KD}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
| Line 12: | Line 14: | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 15:38, 31 January 2013
|
Arteriovenous malformations Microchapters |
|
Differentiating Arteriovenous malformations from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Arteriovenous malformations future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Arteriovenous malformations future or investigational therapies |
|
FDA on Arteriovenous malformations future or investigational therapies |
|
CDC on Arteriovenous malformations future or investigational therapies |
|
Arteriovenous malformations future or investigational therapies in the news |
|
Blogs on Arteriovenous malformations future or investigational therapies |
|
Directions to Hospitals Treating Arteriovenous malformations |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Despite many years of research, the central question of whether to treat AVMs has not been answered. All treatments, whether involving surgery, radiation, or drugs, have risks and side-effects. Therefore, it might be better in some cases to avoid treatment altogether and simply accept a small risk of coming to harm from the AVM itself. This question is currently being addressed in clinical trials.[1].